Phillip Koo, MD, has been appointed chief medical officer of Santa Monica, Calif.-based Prostate Cancer Foundation. Dr. Koo ...

Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.

The reception was part of a weekend of events which included a seminar at Palm Beach Atlantic University and a luncheon at ...

Noetik Names Dr. Emily Corse Executive Vice President of Therapeutics to Accelerate AI-Powered Therapeutics Pipeline ...

James Ragan died more than a decade ago, but his impact on the life of Scottie Scheffler hasn't diminished since they first ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

James Ragan died more than a decade ago, but his impact on the life of Scottie Scheffler hasn't diminished since they first ...

At 38, William Lindley was a father of three kids and passionate about his job in law enforcement. But, after months of ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...